(Q34295077)

1 August 2017

1 reference

title

Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies (English)

1 reference

1 August 2017

Bankert RB

1

1 reference

PubMed ID

11429323

1 August 2017

Egilmez NK

series ordinal

2

1 reference

PubMed ID

11429323

1 August 2017

Hess SD

series ordinal

3

1 reference

1 August 2017

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

22

1 reference

1 August 2017

7

1 reference

1 August 2017

386-393

1 reference

Potential of the scid mouse as a host for human tumors

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Transfer of a functional human immune system to mice with severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

The mouse mutation severe combined immune deficiency (scid) is on chromosome 16.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

The scid mutation in mice causes a general defect in DNA repair

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Murine granulocytes control human tumor growth in SCID mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

The hu-PBL-SCID mouse in human lymphocyte function and lymphomagenesis studies: achievements and caveats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Interleukin-18 acts as an angiogenesis and tumor suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Cytokines delivered by biodegradable microspheres promote effective suppression of human tumors by human peripheral blood lymphocytes in the SCID-Winn model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Enhanced antitumor activity of a combination treatment with a mouse/human chimeric anti-MK-1 antibody and lymphokine-activated killer cells in vitro and in a severe combined immunodeficient mouse xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Immunotoxins for targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

An in vivo model to study immunotoxin-induced vascular leak in human tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

In vivo activation and expansion of T cells by a bi-specific antibody abolishes metastasis formation of human melanoma cells in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

In vivo eradication of an established human melanoma by an in vitro generated autologous cytotoxic T cell clone: a SCID mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Human tumor models in the severe combined immune deficient (scid) mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Colonization of human lung grafts in SCID-hu mice by human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Human inflammatory cells within the tumor microenvironment of lung tumor xenografts mediate tumor growth suppression in situ that depends on and is augmented by interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Tumor-infiltrating B-cell-derived IgG recognizes tumor components in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Establishment of a human cutaneous T-cell lymphoma in C.B-17 SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

Survival of human prostate carcinoma, benign hyperplastic prostate tissues, and IL-2-activated lymphocytes in scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

A natural history of melanoma: serial gene expression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901943-3

7 January 2021

10.1016/S1471-4906(01)01943-3

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11429323